|

BCG Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: BCG Live, TICE®, TheraCys®

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Pfizer1
  • Merck Sharp & Dohme LLC1

Indications

  • Cancer2
  • Carcinoma in Situ1
  • Non-Muscle Invasive Bladder Neoplasms1
  • Urinary Bladder Neoplasms1
  • Non-Muscle Invasive Bladder Cancer1

Birmingham, Alabama1 trial

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

University of Alabama at Birmingham

Phase 1

Bakersfield, California1 trial

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Michael G Oefelein Clinical Trials ( Site 0138)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.